Evangeline G Raulston - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Evangeline G Raulston

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Biorxiv : the Preprint Server for Biology|February 8, 2024

Targetable leukemia dependency on noncanonical PI3Kγ signalingQingyu Luo, Evangeline G Raulston, Miguel A Prado, et al.

Nature|May 8, 2024

Targetable leukaemia dependency on noncanonical PI3Kγ signallingQingyu Luo, Evangeline G Raulston, Miguel A Prado, et al.

Blood Advances|December 5, 2023

Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemiaAndrew A Lane, Jacqueline S Garcia, Evangeline G Raulston, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Biorxiv : the Preprint Server for Biology|February 8, 2024

Targetable leukemia dependency on noncanonical PI3Kγ signalingQingyu Luo, Evangeline G Raulston, Miguel A Prado, et al.

Nature|May 8, 2024

Targetable leukaemia dependency on noncanonical PI3Kγ signallingQingyu Luo, Evangeline G Raulston, Miguel A Prado, et al.

Blood Advances|December 5, 2023

Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemiaAndrew A Lane, Jacqueline S Garcia, Evangeline G Raulston, et al.

Pageof 1